On Tuesday, Cytogen Inc. declared that it will be issuing shares in order to acquire 10 billion won (US$7.4 million). The money obtained from the stock sale will be primarily used to back its operations.
The filing revealed that the corporation will be releasing around 2.75 million ordinary shares at a cost of 14,500 won per share. The stocks will be distributed to the investors appointed by the firm.
(END)